Results · Apr-Jun 2026 · filed 12 Aug 2026
Cravatex Q1 FY27 results
Sales grew 39% to ₹32.2 crore from ₹23.1 crore in Apr-Jun 2025.
Operating profit was −₹3.3 crore, an operating margin of −10.2% (up 16.2 points from a year ago).
Net profit turned positive: ₹0.44 crore against a loss of ₹1.4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −18%, net profit −73%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 32.2 | 23.1 | +39% |
| Operating profit (EBITDA) | -3.3 | -6.1 | n/m |
| Operating margin | −10.2% | −26.4% | +16.2 pts |
| Net profit | 0.4 | -1.4 | turns positive |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 12 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On 12/08/2026
- 12 Aug 2026Unaudited Financial Results For Quarter Ended 30/06/2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.